title: The abnormal quinine drinking aversion in the Brattleboro rat with diabetes insipidus is reversed by the vasopressin agonist DDAVP: a possible role for vasopressin in the motivation to drink.
abstract: The Brattleboro rat with hypothalamic diabetes insipidus (BDI) has an abnormal aversion to drinking quinine-adulterated water compared with normal rats of the parent Long Evans (LE) strain. This BDI animal tolerates marked hypovolemia and decreased body weight in preference to drinking the quinine-adulterated fluid, indicative of a reduced motivation to drink. Acute or chronic treatment of BDI rats with desamino-8D arginine vasopressin (DDAVP) restored to normal their drinking response to quinine solution. Partial restoration of fluid turnover in BDI rats with hydrochlorothiazide, which has an antidiuretic effect in diabetes insipidus (when vasopressin is absent), failed to abolish the abnormal drinking response to quinine-adulterated solution in 8 out of 12 animals. In contrast, induction of diabetes mellitus in LE rats, which resulted in a marked polydipsia and polyuria even though vasopressin was still present, did not impair the drinking response to quinine solutions. These results suggest that the abnormal drinking response to quinine-adulterated fluid in BDI rats is reversed by treatment with the vasopressin V2-receptor agonist DDAVP but is unlikely to be a consequence of the restoration of fluid turnover to normal levels by a renal action. A possible central action involving vasopressin and the motivation to drink is discussed.
authors.affiliation: Department of Physiology, Charing Cross and Westminister Medical School, London, UK.
authors.forename: J F
authors.initials: JF
authors.lastname: Laycock
authors.forename: U
authors.initials: U
authors.lastname: Chatterji
authors.forename: J R
authors.initials: JR
authors.lastname: Seckl
authors.forename: I B
authors.initials: IB
authors.lastname: Gartside
mesh_terms: D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects / Q000502:physiology*; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology*; D003919:Diabetes Insipidus / Q000503:physiopathology*; D004326:Drinking / Q000187:drug effects / Q000502:physiology*; D006185:Habituation, Psychophysiologic / Q000187:drug effects / Q000502:physiology; D006852:Hydrochlorothiazide / Q000494:pharmacology; D008297:Male; D009042:Motivation; D011292:Premedication; D011803:Quinine; D051381:Rats; D011910:Rats, Brattleboro; D013311:Streptozocin / Q000494:pharmacology; D013649:Taste / Q000187:drug effects / Q000502:physiology*; D014667:Vasopressins / Q000037:antagonists & inhibitors / Q000502:physiology*
chemical_list: D006852:Hydrochlorothiazide; D014667:Vasopressins; D013311:Streptozocin; D011803:Quinine; D003894:Deamino Arginine Vasopressin